MED - Interplastsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-05-31
Share capital
62,100.00 PLN
Registered address
ul. Mariana Zdziechowskiego 3/79, 02-659 Warszawa, Poland

Financials

Revenue history (in k)

Financial insight

  • Estonian CIT: Equity includes non-zero Art. 28d line items – the company is taxed under the lump-sum regime on corporate income.

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 69 days for 2021). All were audited by a statutory auditor.

  • 202513/07/2026
  • 202422/07/2025
  • 202309/07/2024
  • 202218/07/2023
  • 202122/09/2022
  • 202005/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Wholesale of pharmaceutical goods249 / 1,141
Top 22%
Division · Wholesale trade2,715 / 19,982
Top 14%
Sector · Wholesale and retail trade; repair of motor vehicles including motorcycles3,790 / 29,896
Top 13%
City · Warszawa3,890 / 56,958
Top 6.8%
Voivodeship · Mazowieckie5,444 / 77,118
Top 7.1%
Country · Poland19,865 / 297,873
Top 6.7%

Results vs industry

Revenue
This companyUSD 9.58mMedianUSD 1.07mAverageUSD 22.38m
Net profit
This companyUSD 1.59mMedianUSD 37.89kAverageUSD 879.28k
Operating costs
This companyUSD 7.76mMedianUSD 929.75kAverageUSD 21.06m
Assets
This companyUSD 14.41mMedianUSD 609.81kAverageUSD 11.84m

Industry

Public procurement

1 tender recorded as contractor, with a total value of $26,345.

SubjectAmount
EOP.332.6.25 Comprehensive organization of the XXII International Polish Medical Rescue Championships
$26,345

Trademarks

MED - Interplast currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2003.

MarkNumberClassesStatusProtected until
Osteoplus Ipriflavone(word)Z.2724975Refused –
MarkProtected until
Osteoplus Ipriflavone(word)–

Authorized Representatives

Ala Tryzonova – Management Board Member
Yury Mikhaliou – President of the Management Board

Manner of representation

The President of the Management Board represents the company independently in the case of a one-person management board. In the case of a multi-member management board, each member of the management board is authorised to act on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Yury Mikhaliouage 70
62,100$16,774.72100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1999-05-17.

  • Bank spółdzielczy
    Bank spółdzielczy
    58 8099 0004 0010 4364 2000 0040
  • mBank
    mBank
    57 1140 1775 0000 5888 5600 1001
  • mBank
    mBank
    30 1140 1775 0000 5888 5600 1002

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$452.5K
Buildings and premises
$5.7M

Public aid

5 public aid cases recorded, with a total value of $395,656.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Intimexsp. z o.o. + limited partnership
Ivoclar-Vivadent Polskasp. z o.o.
AO East Europesp. z o.o.
Medif sp. z o.o.sp. k.
PromedS.A.
MassmedicaS.A.
Billmedsp. z o.o.
SPA Landsp. z o.o.
Medmess Kropaczewskisp. k.
IMC Impomed CentrumS.A.

Change history

DateEvent
2024-12-31Share capital increase
2023-03-21Address change
2002-08-28Address change
2002-08-14Address change
2002-08-09Name change

FAQ

Last updated: 2026-10-07